BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34732714)

  • 21. Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasms.
    Andersen CL; Hasselbalch H; Grønbæk K
    Leuk Res; 2012 Apr; 36(4):485-7. PubMed ID: 22177454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells.
    Dutto I; Scalera C; Tillhon M; Ticli G; Passaniti G; Cazzalini O; Savio M; Stivala LA; Gervasini C; Larizza L; Prosperi E
    Carcinogenesis; 2020 May; 41(3):257-266. PubMed ID: 31504229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.
    Lopez-Atalaya JP; Gervasini C; Mottadelli F; Spena S; Piccione M; Scarano G; Selicorni A; Barco A; Larizza L
    J Med Genet; 2012 Jan; 49(1):66-74. PubMed ID: 21984751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming.
    Ebrahimi A; Sevinç K; Gürhan Sevinç G; Cribbs AP; Philpott M; Uyulur F; Morova T; Dunford JE; Göklemez S; Arı Ş; Oppermann U; Önder TT
    Nat Chem Biol; 2019 May; 15(5):519-528. PubMed ID: 30962627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.
    Hashwah H; Schmid CA; Kasser S; Bertram K; Stelling A; Manz MG; Müller A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9701-9706. PubMed ID: 28831000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters.
    Hsu E; Pennella MA; Zemke NR; Eng C; Berk AJ
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct roles for CBP and p300 on the RA-mediated expression of the meiosis commitment gene Stra8 in mouse embryonic stem cells.
    Chen W; Jia W; Wang K; Si X; Zhu S; Duan T; Kang J
    PLoS One; 2013; 8(6):e66076. PubMed ID: 23785470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300.
    Williams LM; McCann FE; Cabrita MA; Layton T; Cribbs A; Knezevic B; Fang H; Knight J; Zhang M; Fischer R; Bonham S; Steenbeek LM; Yang N; Sood M; Bainbridge C; Warwick D; Harry L; Davidson D; Xie W; Sundstrӧm M; Feldmann M; Nanchahal J
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20753-20763. PubMed ID: 32759223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.
    Ghosh S; Taylor A; Chin M; Huang HR; Conery AR; Mertz JA; Salmeron A; Dakle PJ; Mele D; Cote A; Jayaram H; Setser JW; Poy F; Hatzivassiliou G; DeAlmeida-Nagata D; Sandy P; Hatton C; Romero FA; Chiang E; Reimer T; Crawford T; Pardo E; Watson VG; Tsui V; Cochran AG; Zawadzke L; Harmange JC; Audia JE; Bryant BM; Cummings RT; Magnuson SR; Grogan JL; Bellon SF; Albrecht BK; Sims RJ; Lora JM
    J Biol Chem; 2016 Jun; 291(25):13014-27. PubMed ID: 27056325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rubinstein-Taybi syndrome: clinical and molecular overview.
    Roelfsema JH; Peters DJ
    Expert Rev Mol Med; 2007 Aug; 9(23):1-16. PubMed ID: 17942008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.
    Brand M; Clayton J; Moroglu M; Schiedel M; Picaud S; Bluck JP; Skwarska A; Bolland H; Chan AKN; Laurin CMC; Scorah AR; See L; Rooney TPC; Andrews KH; Fedorov O; Perell G; Kalra P; Vinh KB; Cortopassi WA; Heitel P; Christensen KE; Cooper RI; Paton RS; Pomerantz WCK; Biggin PC; Hammond EM; Filippakopoulos P; Conway SJ
    J Med Chem; 2021 Jul; 64(14):10102-10123. PubMed ID: 34255515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor.
    Kanada R; Kagoshima Y; Suzuki T; Nakamura A; Funami H; Watanabe J; Asano M; Takahashi M; Ubukata O; Suzuki K; Aikawa T; Sato K; Goto M; Setsu G; Ito K; Kihara K; Kuroha M; Kohno T; Ogiwara H; Isoyama T; Tominaga Y; Higuchi S; Naito H
    J Med Chem; 2023 Jan; 66(1):695-715. PubMed ID: 36572866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.
    Wong CK; Wade-Vallance AK; Luciani DS; Brindle PK; Lynn FC; Gibson WT
    Diabetes; 2018 Mar; 67(3):412-422. PubMed ID: 29217654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes.
    Ogiwara H; Kohno T
    PLoS One; 2012; 7(12):e52810. PubMed ID: 23285190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways.
    Kasper LH; Thomas MC; Zambetti GP; Brindle PK
    Cell Cycle; 2011 Jan; 10(2):212-21. PubMed ID: 21220944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is histone acetylation the most important physiological function for CBP and p300?
    Bedford DC; Brindle PK
    Aging (Albany NY); 2012 Apr; 4(4):247-55. PubMed ID: 22511639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines.
    Garcia-Carpizo V; Ruiz-Llorente S; Sarmentero J; González-Corpas A; Barrero MJ
    Mol Cancer Res; 2019 Mar; 17(3):720-730. PubMed ID: 30606771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two independent regions of simian virus 40 T antigen increase CBP/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells.
    Sáenz Robles MT; Shivalila C; Wano J; Sorrells S; Roos A; Pipas JM
    J Virol; 2013 Dec; 87(24):13499-509. PubMed ID: 24089570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18.
    Liu Y; Xing ZB; Zhang JH; Fang Y
    FEBS Lett; 2013 Apr; 587(7):847-53. PubMed ID: 23434580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E2F1 acetylation directs p300/CBP-mediated histone acetylation at DNA double-strand breaks to facilitate repair.
    Manickavinayaham S; Vélez-Cruz R; Biswas AK; Bedford E; Klein BJ; Kutateladze TG; Liu B; Bedford MT; Johnson DG
    Nat Commun; 2019 Oct; 10(1):4951. PubMed ID: 31666529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.